-
Cipher Pharmaceuticals Inc. (CPH $14.21)
- $14.21 P/E (TTM): 15.43X Cap: $360M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Detailed Quote
5i Report
Review of Cipher Pharmaceuticals
AUG 16, 2018 - Dermatology pharmaceutical business with recent acquisition and growth in product pipeline, with some mixed results in the past. Coverage dropped until some visibility emerges.
Download ReportCompany Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Cipher Pharmaceuticals Inc. (CPH $14.21)
- $14.21 P/E (TTM): 15.43X Cap: $360M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
-
Krystal Biotech Inc. (KRYS $246.78)
- $246.78 P/E (TTM): 35.13X Cap: $6.78B
- View KRYS Profile
- View Questions on KRYS
Q: I'm analyzing some pharma companies for a potential single company to add to the portfolio. I know you like Cipher in Canada. I'm looking for outsized long term returns, so I'm excluding mega caps like Eli Lilly etc. More looking to get in earlier and hold a company that has the criteria to be a big name down the road. Can you compare CPH to KRYS, which is a US company that filters pretty well for what I'm looking for. Let me know which of the 2 looks like the better choice? Thx
-
Cipher Pharmaceuticals Inc. (CPH $14.21)
- $14.21 P/E (TTM): 15.43X Cap: $360M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
-
Firan Technology Group Corporation (FTG $11.09)
- $11.09 P/E (TTM): 25.86X Cap: $279M
- View FTG Profile
- View Questions on FTG
- View Reports on FTG
-
Stingray Group Inc. Subordinate Voting Shares (RAY.A $13.89)
- $13.89 P/E (TTM): 18.45X Cap: $943M
- View RAY.A Profile
- View Questions on RAY.A
-
HIVE Digital Technologies Ltd. (HIVE $4.45)
- $4.45 P/E (TTM): 26.22X Cap: $1.05B
- View HIVE Profile
- View Questions on HIVE
-
Zoomd Technologies Ltd. (ZOMD $1.30)
- $1.30 P/E (TTM): 5.48X Cap: $131M
- View ZOMD Profile
- View Questions on ZOMD
-
Telesat Corporation Common and Variable Voting Shares (TSAT $48.63)
- $48.63 Cap: $1.75B
- View TSAT Profile
- View Questions on TSAT
Q: Your portfolio manager(s) on the Growth portfolio have been very active lately. I own a lot of the growth but a bunch of new names have come up and I don't have room for all of them
Can you please prioritize of those names listed above which ones offer the best growth over the next 5 years.
Can you please list in order of highest to lowest conviction.
Thanks
Sheldon
Can you please prioritize of those names listed above which ones offer the best growth over the next 5 years.
Can you please list in order of highest to lowest conviction.
Thanks
Sheldon
-
Knight Therapeutics Inc. (GUD $6.08)
- $6.08 Cap: $606M
- View GUD Profile
- View Questions on GUD
- View Reports on GUD
-
Savaria Corporation (SIS $21.85)
- $21.85 P/E (TTM): 25.15X Cap: $1.56B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS
-
Cipher Pharmaceuticals Inc. (CPH $14.21)
- $14.21 P/E (TTM): 15.43X Cap: $360M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
-
Vitalhub Corp. (VHI $8.87)
- $8.87 P/E (TTM): 178.43X Cap: $567M
- View VHI Profile
- View Questions on VHI
- View Reports on VHI
-
WELL Health Technologies Corp. (WELL $4.07)
- $4.07 Cap: $1.03B
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
-
DRI Healthcare Trust (DHT.UN $16.86)
- $16.86 Cap: $929M
- View DHT.UN Profile
- View Questions on DHT.UN
-
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.92)
- $0.92 Cap: $284M
- View AIDX Profile
- View Questions on AIDX
Q: how do you rank them to buy now 1 to 10 after the q3 reported. thanks
Insiders
Share Information
News and Media